These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2207327)

  • 41. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
    Schleef RR; Wagner NV; Loskutoff DJ
    J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis.
    Praus M; Collen D; Gerard RD
    Int J Cancer; 2002 Dec; 102(6):584-91. PubMed ID: 12447999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
    Hekman CM; Loskutoff DJ
    J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring plasminogen activator inhibitor activity in plasma by two enzymatic assays.
    Chiu WC; Gann DS; Darlington DN
    J Biochem Biophys Methods; 2000 Sep; 45(2):127-40. PubMed ID: 10989129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Denaturant-induced stimulation of the beta-migrating plasminogen activator inhibitor in endothelial cells and serum.
    Erickson LA; Hekman CM; Loskutoff DJ
    Blood; 1986 Dec; 68(6):1298-305. PubMed ID: 2430646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
    Bergonzelli GE; Kruithof EK
    J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
    Cajot JF; Bamat J; Bergonzelli GE; Kruithof EK; Medcalf RL; Testuz J; Sordat B
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):6939-43. PubMed ID: 2169614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.
    Franke AE; Danley DE; Kaczmarek FS; Hawrylik SJ; Gerard RD; Lee SE; Geoghegan KF
    Biochim Biophys Acta; 1990 Jan; 1037(1):16-23. PubMed ID: 2403813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.
    Declerck PJ; De Mol M; Vaughan DE; Collen D
    J Biol Chem; 1992 Jun; 267(17):11693-6. PubMed ID: 1601844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
    Crandall DL; Elokdah H; Di L; Hennan JK; Gorlatova NV; Lawrence DA
    J Thromb Haemost; 2004 Aug; 2(8):1422-8. PubMed ID: 15304050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat.
    Larsen GR; Metzger M; Henson K; Blue Y; Horgan P
    Blood; 1989 May; 73(7):1842-50. PubMed ID: 2496774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.
    Schleef RR; Loskutoff DJ; Podor TJ
    J Cell Biol; 1991 Jun; 113(6):1413-23. PubMed ID: 2045419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.
    Dawson S; Hamsten A; Wiman B; Henney A; Humphries S
    Arterioscler Thromb; 1991; 11(1):183-90. PubMed ID: 1670989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator.
    Orth K; Willnow T; Herz J; Gething MJ; Sambrook J
    J Biol Chem; 1994 Aug; 269(33):21117-22. PubMed ID: 8063731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    J Biol Chem; 1991 Mar; 266(7):4041-4. PubMed ID: 1900284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
    Stefansson S; Lawrence DA; Argraves WS
    J Biol Chem; 1996 Apr; 271(14):8215-20. PubMed ID: 8626514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
    J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of nitric oxide donors on the release of plasminogen activator inhibitor (PAI) from rabbit platelets in vitro.
    Korbut R; Marcinkiewicz E; Cieślik K; Gryglewski RJ
    J Physiol Pharmacol; 1995 Mar; 46(1):37-44. PubMed ID: 7599336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.